Here are five things to know about the sale:
1. K2M sold 906,748 shares of common stock in their follow-on offering pursuant to the underwriters’ option to purchase additional shares.
2. The shares were purchased at $18.75 per share before underwriting discounts.
3. K2M didn’t receive any proceeds from the sale.
4. Piper Jaffray & Co., Barclays Capital and Wells Fargo Securities are joint book-running managers for the offering.
5. William Blair & Company and Cowen and Company are co-managers.
There has also been a great deal of action for individuals selling stock over the past few days:
• John Philip Kostuik, MD, sold 83,807 shares in a $1.4 million transaction
• Director Ray A. Ranelli sold 14,000 shares in a $262,500 transaction
• Wcas Management sold 3,738 shares in a $70,087.50 transaction
More articles on orthopedic devices:
7 key trends in joint replacement customization
Smith & Nephew launches new suture anchor
Smith & Nephew launches new suture anchor
